...
首页> 外文期刊>Clinics and research in hepatology and gastroenterology >MicroRNAs in cholangiopathies: Potential diagnostic and therapeutic tools
【24h】

MicroRNAs in cholangiopathies: Potential diagnostic and therapeutic tools

机译:胆管病中的MicroRNA:潜在的诊断和治疗工具

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Cholangiopathies are the group of diseases targeting the bile duct epithelial cells (i.e. cholangiocytes). These disorders arise from different etiologies and represent a current diagnostic, prognostic and therapeutic challenge. Different molecular mechanisms participate in the development and progression of each type of biliary disease. However, microRNA deregulation is a common central event occurring in all of them that plays a key role in their pathogenesis. MicroRNAs are highly stable small non-coding RNAs present in cells, extracellular microvesicles and biofluids, representing valuable diagnostic tools and potential targets for therapy. In the following sections, the most novel and significant discoveries in this field are summarized and their potential clinical value is highlighted. (C) 2015 Elsevier Masson SAS. All rights reserved.
机译:胆管病是针对胆管上皮细胞(即胆管细胞)的疾病。这些疾病源于不同的病因,代表了当前的诊断,预后和治疗挑战。不同的分子机制参与每种类型的胆道疾病的发生和发展。然而,microRNA的失调是所有常见的中心事件,在其发病机理中起着关键作用。 MicroRNA是存在于细胞,细胞外微泡和生物流体中的高度稳定的小型非编码RNA,代表有价值的诊断工具和潜在的治疗靶标。在以下各节中,总结了该领域中最新颖和重要的发现,并突出了它们的潜在临床价值。 (C)2015 Elsevier Masson SAS。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号